Who we are

Our Mission
Keystone Biologics Advisory provides independent, principal-led CMC guidance for programs from discovery through to late-stage development. We specialise in complex biologics—including cell and gene therapies—helping biotech innovators build readiness for CTN, US FDA INTERACT, pre-IND meetings, IND, and BLA submissions.

Strategic Partnership
We work directly with founders and scientists to provide strategic oversight, ensuring CMC programs are practical, structured, and phase-appropriate. In an evolving regulatory landscape, our deep expertise ensures your manufacturing and quality strategies are optimised for success in alignment with current TGA and FDA expectations.

The Keystone Approach
We collaborate closely with founders, institutes, sponsors, and investors, offering high-level guidance without the overhead of in-house teams or operational staff. Our approach is discreet, precise, and experience-driven—designed to bridge the gap between breakthrough science and regulatory approval.